The present invention is directed to novel alkynyl derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by DPP-1.L'invention concerne de nouveaux dérivés d'alkynyle, des compositions pharmaceutiques les contenant et leur utilisation dans le traitement de troubles et d'états modulés par DPP-1.